Olanzapine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68462-952

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 68462-952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
Packaging label for Olanzapine for Injection 10 mg/vial, a sterile single-dose vial for intramuscular use. The label includes the NDC 68462-952-10 and the Glenmark Pharmaceuticals logo. It advises storage conditions, reconstitution instructions, and notes the product is distributed by Glenmark Pharmaceuticals Inc., USA, with product origin stated as China.*
FDA Label Image
FDA Label Image

"image Description" (Olanzapine Injection Structure)

"image Description" (Olanzapine Injection Structure)
Chemical structure of olanzapine, the active ingredient in OLANZAPINE injection, powder, lyophilized, for solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.